Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the United States for their patent-pending CBD Relief &GO pain relief collection.
Bincovich talks about the collection and when they would like to have it in stores and online. She also discussed the latest on their research into Covid-19.
CSE:INNO
Market: CSE
Market Cap: $33.09 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Innocan Pharma launches Derma CBD line in Europe
Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company has launched their CBD derma line. Bincovich discusses where it is being made and the first areas of the world it is being rolled out to. Bincovich also told gave Proactive an update...
on 06/08/2020
2 min read
Prev article
3 min read